140 related articles for article (PubMed ID: 17308895)
1. Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004.
Wu HX; Wu J; Wong T; Andonov A; Li Q; Dinner K; Donaldson T; Paton S;
Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):167-74. PubMed ID: 17308895
[TBL] [Abstract][Full Text] [Related]
2. Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian Aboriginal.
Parmar P; Corsi DJ; Cooper C
Can J Gastroenterol Hepatol; 2016; 2016():8987976. PubMed ID: 27446875
[TBL] [Abstract][Full Text] [Related]
3. The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities.
Spittal PM; Pearce ME; Chavoshi N; Christian WM; Moniruzzaman A; Teegee M; Schechter MT
BMC Public Health; 2012 Aug; 12():632. PubMed ID: 22877418
[TBL] [Abstract][Full Text] [Related]
4. Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004.
Wu HX; Wu J; Wong T; Donaldson T; Dinner K; Andonov A; Ip Chan J; Moffat B; Baptiste B; Furseth J; Poliquin D; Bolesnikov G; Giulivi A; Paton S
Scand J Infect Dis; 2006; 38(6-7):482-9. PubMed ID: 16798699
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in HIV and hepatitis C related vulnerabilities among aboriginal young people who use street drugs in two Canadian cities.
; Mehrabadi A; Paterson K; Pearce M; Patel S; Craib KJ; Moniruzzaman A; Schechter MT; Spittal PM
Women Health; 2008; 48(3):235-60. PubMed ID: 19191041
[TBL] [Abstract][Full Text] [Related]
6. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities.
Mehrabadi A; Craib KJ; Patterson K; Adam W; Moniruzzaman A; Ward-Burkitt B; Schechter MT; Spittal PM;
Int J Drug Policy; 2008 Apr; 19(2):159-68. PubMed ID: 17870461
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
Craib KJ; Spittal PM; Wood E; Laliberte N; Hogg RS; Li K; Heath K; Tyndall MW; O'Shaughnessy MV; Schechter MT
CMAJ; 2003 Jan; 168(1):19-24. PubMed ID: 12515780
[TBL] [Abstract][Full Text] [Related]
8. Risk indicators associated with injection drug use in the Aboriginal population.
Lemstra M; Rogers M; Thompson A; Moraros J; Buckingham R
AIDS Care; 2012; 24(11):1416-24. PubMed ID: 22292863
[TBL] [Abstract][Full Text] [Related]
9. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users.
Roy E; Alary M; Morissette C; Leclerc P; Boudreau JF; Parent R; Rochefort J; Claessens C;
Int J STD AIDS; 2007 Jan; 18(1):23-7. PubMed ID: 17326858
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of severe trauma among status Aboriginal Canadians: a population-based study.
Karmali S; Laupland K; Harrop AR; Findlay C; Kirkpatrick AW; Winston B; Kortbeek J; Crowshoe L; Hameed M
CMAJ; 2005 Apr; 172(8):1007-11. PubMed ID: 15824405
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
Fuller CM; Ompad DC; Galea S; Wu Y; Koblin B; Vlahov D
J Urban Health; 2004 Mar; 81(1):20-4. PubMed ID: 15047780
[TBL] [Abstract][Full Text] [Related]
12. Risk practices among aboriginal people who inject drugs in New South Wales, Australia.
Paquette D; McEwan M; Bryant J
AIDS Behav; 2013 Sep; 17(7):2467-73. PubMed ID: 22711223
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.
Roy E; Boudreau JF; Boivin JF
Drug Alcohol Depend; 2009 Jun; 102(1-3):158-61. PubMed ID: 19251382
[TBL] [Abstract][Full Text] [Related]
14. Injury hospitalizations due to unintentional falls among the Aboriginal population of British Columbia, Canada: incidence, changes over time, and ecological analysis of risk markers, 1991-2010.
Jin A; Lalonde CE; Brussoni M; McCormick R; George MA
PLoS One; 2015; 10(3):e0121694. PubMed ID: 25793298
[TBL] [Abstract][Full Text] [Related]
15. Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000.
Hammer GP; Kellogg TA; McFarland WC; Wong E; Louie B; Williams I; Dilley J; Page-Shafer K; Klausner JD
Sex Transm Dis; 2003 Dec; 30(12):919-24. PubMed ID: 14646642
[TBL] [Abstract][Full Text] [Related]
16. The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China.
Bao YP; Du C; Lu HY; Lian Z; Qiu Y; Mu Y; Yan SY; Liu ZM
Am J Drug Alcohol Abuse; 2012 Mar; 38(2):140-5. PubMed ID: 22175771
[TBL] [Abstract][Full Text] [Related]
17. The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people.
Miller CL; Pearce ME; Moniruzzaman A; Thomas V; Christian W; Schechter MT; Spittal PM;
CMAJ; 2011 Jul; 183(10):1147-54. PubMed ID: 21670106
[TBL] [Abstract][Full Text] [Related]
18. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus reinfection in injection drug users.
Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
